Pharmacists in 2023 – unlocking the future of pharmacy

A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...

Systemic corticosteroids for dyspnoea

The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

NSW pharmacists given special authority to supply essential medicines

NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires. The NSW Chief Health...

First 100,000 Australians receive COVID-19 vaccines

More than 100,000 Australians have received their first COVID-19 vaccination, and the country now has 1.3 million doses on hand for the next rollout phases.

Complementary medicines: Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...

New alliance between PSA and SHPA announced

At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...